Boxer Capital’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-563,067
| Closed | -$12.7M | – | 33 |
|
|
2024
Q3 | $12.7M | Buy |
+563,067
| New | +$12.7M | 0.62% | 41 |
|
|
2023
Q4 | – | Sell |
-1,224,892
| Closed | -$9.63M | – | 64 |
|
|
2023
Q3 | $9.63M | Hold |
1,224,892
| – | – | 0.51% | 42 |
|
|
2023
Q2 | $12.2M | Hold |
1,224,892
| – | – | 0.57% | 45 |
|
|
2023
Q1 | $10.9M | Hold |
1,224,892
| – | – | 0.53% | 43 |
|
|
2022
Q4 | $13.4M | Hold |
1,224,892
| – | – | 0.71% | 39 |
|
|
2022
Q3 | $16M | Hold |
1,224,892
| – | – | 0.9% | 39 |
|
|
2022
Q2 | $15.5M | Hold |
1,224,892
| – | – | 0.98% | 35 |
|
|
2022
Q1 | $17.2M | Hold |
1,224,892
| – | – | 0.88% | 35 |
|
|
2021
Q4 | $35.5M | Hold |
1,224,892
| – | – | 1.38% | 19 |
|
|
2021
Q3 | $36.7M | Hold |
1,224,892
| – | – | 1.28% | 23 |
|
|
2021
Q2 | $32.5M | Hold |
1,224,892
| – | – | 1.15% | 24 |
|
|
2021
Q1 | $38.1M | Hold |
1,224,892
| – | – | 1.29% | 23 |
|
|
2020
Q4 | $40.3M | Sell |
1,224,892
-129,500
| -10% | -$4.26M | 1.29% | 23 |
|
|
2020
Q3 | $47.3M | Buy |
+1,354,392
| New | +$47.3M | 1.63% | 15 |
|